TECHNOLOGY LICENSING OPPORTUNITY: SignalGen
TECHNOLOGY LICENSING OPPORTUNITY: SignalGen is a published development and funding opportunity on Contexium. The donor or funder is ENERGY, DEPARTMENT OF. Project location(s): United States. Applications close on 22 Mar 2027. A platform that predicts the right signal peptide for a specific protein Many medicines, vaccines, and biotechnology products rely on proteins reaching the right cellular compartment or secretion outside a cell. Whether a protein gets there in enough quantities depends on its signal peptide or leade…
Opportunity overview
- Project name
- TECHNOLOGY LICENSING OPPORTUNITY: SignalGen
- Donor
- ENERGY, DEPARTMENT OF
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is TECHNOLOGY LICENSING OPPORTUNITY: SignalGen?
TECHNOLOGY LICENSING OPPORTUNITY: SignalGen is a published development and funding opportunity on Contexium. The donor or funder is ENERGY, DEPARTMENT OF. Project location(s): United States. Applications close on 22 Mar 2027. A platform that predicts the right signal peptide for a specific protein Many medicines, vaccines, and biotechnology products rely on proteins reaching the right cellular compartment or secretion outside a cell. Whether a protein gets there in enough quantities depends on its signal peptide or leade…
Who is funding TECHNOLOGY LICENSING OPPORTUNITY: SignalGen?
TECHNOLOGY LICENSING OPPORTUNITY: SignalGen is funded by ENERGY, DEPARTMENT OF.
When is the deadline to apply for TECHNOLOGY LICENSING OPPORTUNITY: SignalGen?
The application deadline is 22 Mar 2027 17:00 (UTC).
Where will the TECHNOLOGY LICENSING OPPORTUNITY: SignalGen project take place?
The project location(s) are: United States.
How can I apply for TECHNOLOGY LICENSING OPPORTUNITY: SignalGen?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.